A recent health economics and outcomes study, conducted by leading health economists and supported by Abbott, found that oral nutritional supplements provided to patients during hospitalization were associated with significant reductions in length of stay and hospitalization cost. Additionally, the 30-day readmission risk was significantly reduced for patients with at least one known subsequent readmission.
The study is being presented this weekend at the European Society for Clinical Nutrition and Metabolism (ESPEN) annual congress in Leipzig, Germany, where it will be highlighted as one of the conference’s three “Best Abstracts.” The meeting is a leading conference in clinical nutrition, bringing together participants from more than 80 countries.
The study analyzed more than 1 million adult inpatient cases in the U.S., and found that patients provided oral nutritional supplements during hospitalization benefited from:
- 21 percent, or 2.3 day, reduction in length of stay
- 21.6 percent, or $4,734, reduction in patient hospitalization cost
ASK ABOUT THE NEXT WEIGHT LOSS CHALLENGE
4443 Breton Rd SE, Grand Rapids, MI
(Next to H&R Block in Horrock’s plaza)